nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—IRX4—salivary gland cancer	0.0862	0.0862	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—CNTN6—salivary gland cancer	0.0559	0.0559	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—ISL1—salivary gland cancer	0.0522	0.0522	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—CNTN6—salivary gland cancer	0.0452	0.0452	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—CNTN6—salivary gland cancer	0.0432	0.0432	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—CNTN6—salivary gland cancer	0.0415	0.0415	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—CNTN6—salivary gland cancer	0.0415	0.0415	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—CNTN6—salivary gland cancer	0.04	0.04	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—CNTN6—salivary gland cancer	0.04	0.04	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—CNTN6—salivary gland cancer	0.0282	0.0282	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EN1—salivary gland cancer	0.0275	0.0275	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—CNTN6—salivary gland cancer	0.0211	0.0211	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—CNTN6—salivary gland cancer	0.0171	0.0171	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—CNTN6—salivary gland cancer	0.0163	0.0163	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—CNTN6—salivary gland cancer	0.0157	0.0157	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—CNTN6—salivary gland cancer	0.0157	0.0157	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—MAP2K2—salivary gland cancer	0.0153	0.0153	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—CNTN6—salivary gland cancer	0.0151	0.0151	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—CNTN6—salivary gland cancer	0.0151	0.0151	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CNTN6—salivary gland cancer	0.0151	0.0151	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—MAP2K2—salivary gland cancer	0.0124	0.0124	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CNTN6—salivary gland cancer	0.0122	0.0122	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—MAP2K2—salivary gland cancer	0.0119	0.0119	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CNTN6—salivary gland cancer	0.0117	0.0117	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—MAP2K2—salivary gland cancer	0.0114	0.0114	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—MAP2K2—salivary gland cancer	0.0114	0.0114	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CNTN6—salivary gland cancer	0.0112	0.0112	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CNTN6—salivary gland cancer	0.0112	0.0112	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—MAP2K2—salivary gland cancer	0.011	0.011	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—MAP2K2—salivary gland cancer	0.011	0.011	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CNTN6—salivary gland cancer	0.0108	0.0108	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CNTN6—salivary gland cancer	0.0108	0.0108	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—CNTN6—salivary gland cancer	0.0106	0.0106	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.0106	0.0106	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—salivary gland cancer	0.0102	0.0102	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—MAP2K2—salivary gland cancer	0.00772	0.00772	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CNTN6—salivary gland cancer	0.00759	0.00759	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MAP2K2—salivary gland cancer	0.00579	0.00579	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—FOXO3—salivary gland cancer	0.00506	0.00506	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAP2K2—salivary gland cancer	0.00468	0.00468	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAP2K2—salivary gland cancer	0.00448	0.00448	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAP2K2—salivary gland cancer	0.0043	0.0043	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAP2K2—salivary gland cancer	0.0043	0.0043	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAP2K2—salivary gland cancer	0.00415	0.00415	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAP2K2—salivary gland cancer	0.00415	0.00415	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAP2K2—salivary gland cancer	0.00413	0.00413	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—FOXO3—salivary gland cancer	0.00409	0.00409	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—FOXO3—salivary gland cancer	0.00391	0.00391	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00389	0.00389	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—FOXO3—salivary gland cancer	0.00376	0.00376	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—FOXO3—salivary gland cancer	0.00376	0.00376	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FOXO3—salivary gland cancer	0.00363	0.00363	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—FOXO3—salivary gland cancer	0.00363	0.00363	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NOTCH1—salivary gland cancer	0.00339	0.00339	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAP2K2—salivary gland cancer	0.00334	0.00334	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAP2K2—salivary gland cancer	0.0032	0.0032	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAP2K2—salivary gland cancer	0.00307	0.00307	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAP2K2—salivary gland cancer	0.00307	0.00307	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CREBBP—salivary gland cancer	0.00307	0.00307	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAP2K2—salivary gland cancer	0.00296	0.00296	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAP2K2—salivary gland cancer	0.00296	0.00296	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAP2K2—salivary gland cancer	0.00292	0.00292	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NOTCH1—salivary gland cancer	0.00274	0.00274	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.00265	0.00265	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NOTCH1—salivary gland cancer	0.00262	0.00262	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FOXO3—salivary gland cancer	0.00255	0.00255	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NOTCH1—salivary gland cancer	0.00252	0.00252	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NOTCH1—salivary gland cancer	0.00252	0.00252	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CREBBP—salivary gland cancer	0.00248	0.00248	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NOTCH1—salivary gland cancer	0.00243	0.00243	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NOTCH1—salivary gland cancer	0.00243	0.00243	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CREBBP—salivary gland cancer	0.00237	0.00237	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CREBBP—salivary gland cancer	0.00228	0.00228	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CREBBP—salivary gland cancer	0.00228	0.00228	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CREBBP—salivary gland cancer	0.0022	0.0022	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CREBBP—salivary gland cancer	0.0022	0.0022	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EP300—salivary gland cancer	0.00209	0.00209	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAP2K2—salivary gland cancer	0.00208	0.00208	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HRAS—salivary gland cancer	0.002	0.002	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NOTCH1—salivary gland cancer	0.00171	0.00171	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EP300—salivary gland cancer	0.00169	0.00169	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—salivary gland cancer	0.00162	0.00162	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EP300—salivary gland cancer	0.00162	0.00162	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EP300—salivary gland cancer	0.00155	0.00155	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EP300—salivary gland cancer	0.00155	0.00155	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—salivary gland cancer	0.00155	0.00155	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CREBBP—salivary gland cancer	0.00155	0.00155	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EP300—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EP300—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—salivary gland cancer	0.00149	0.00149	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—salivary gland cancer	0.00149	0.00149	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—salivary gland cancer	0.00144	0.00144	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—salivary gland cancer	0.00144	0.00144	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—salivary gland cancer	0.00143	0.00143	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—salivary gland cancer	0.00116	0.00116	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—salivary gland cancer	0.00111	0.00111	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—salivary gland cancer	0.00106	0.00106	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—salivary gland cancer	0.00106	0.00106	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EP300—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—salivary gland cancer	0.000721	0.000721	CbGpPWpGaD
